Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CHF 205.21 billion. The enterprise value is 223.83 billion.

Market Cap	205.21B
Enterprise Value	223.83B

Important Dates

The next estimated earnings date is Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Novartis AG has 2.02 billion shares outstanding. The number of shares has decreased by -3.53% in one year.

Shares Outstanding	2.02B
Shares Change (YoY)	-3.53%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	38.41%
Float	1.93B

Valuation Ratios

The trailing PE ratio is 23.09 and the forward PE ratio is 15.14. Novartis AG's PEG ratio is 1.69.

PE Ratio	23.09
Forward PE	15.14
PS Ratio	4.73
PB Ratio	5.47
P/FCF Ratio	16.42
PEG Ratio	1.69

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.77, with an EV/FCF ratio of 17.91.

EV / Earnings	15.40
EV / Sales	5.10
EV / EBITDA	12.77
EV / EBIT	16.90
EV / FCF	17.91

Financial Position

The company has a current ratio of 0.93, with a Debt / Equity ratio of 69.18.

Current Ratio	0.93
Quick Ratio	0.61
Debt / Equity	69.18
Debt / EBITDA	1.48
Debt / FCF	2.08
Interest Coverage	16.31

Financial Efficiency

Return on equity (ROE) is 21.50% and return on invested capital (ROIC) is 12.22%.

Return on Equity (ROE)	21.50%
Return on Assets (ROA)	8.86%
Return on Capital (ROIC)	12.22%
Revenue Per Employee	577,272
Profits Per Employee	191,105
Employee Count	76,057
Asset Turnover	0.47
Inventory Turnover	1.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.22% in the last 52 weeks. The beta is 0.50, so Novartis AG's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+13.22%
50-Day Moving Average	98.08
200-Day Moving Average	91.41
Relative Strength Index (RSI)	56.69
Average Volume (20 Days)	2,341,191

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CHF 43.91 billion and earned 14.53 billion in profits. Earnings per share was 7.04.

Revenue	43.91B
Gross Profit	33.17B
Operating Income	13.28B
Pretax Income	9.79B
Net Income	14.53B
EBITDA	17.34B
EBIT	13.28B
Earnings Per Share (EPS)	7.04

Full Income Statement

Balance Sheet

The company has 7.58 billion in cash and 26.05 billion in debt, giving a net cash position of -18.47 billion or -9.12 per share.

Cash & Cash Equivalents	7.58B
Total Debt	26.05B
Net Cash	-18.47B
Net Cash Per Share	-9.12
Equity (Book Value)	37.65B
Book Value Per Share	18.52
Working Capital	-1.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.54 billion and capital expenditures -1.04 billion, giving a free cash flow of 12.50 billion.

Operating Cash Flow	13.54B
Capital Expenditures	-1.04B
Free Cash Flow	12.50B
FCF Per Share	6.17

Full Cash Flow Statement

Margins

Gross margin is 75.55%, with operating and profit margins of 30.25% and 33.10%.

Gross Margin	75.55%
Operating Margin	30.25%
Pretax Margin	22.31%
Profit Margin	33.10%
EBITDA Margin	39.49%
EBIT Margin	30.25%
FCF Margin	28.47%

Dividends & Yields

This stock pays an annual dividend of 3.30, which amounts to a dividend yield of 3.26%.

Dividend Per Share	3.30
Dividend Yield	3.26%
Dividend Growth (YoY)	153.13%
Years of Dividend Growth	3
Payout Ratio	47.13%
Buyback Yield	3.53%
Shareholder Yield	6.79%
Earnings Yield	6.95%
FCF Yield	6.09%

Dividend Details

Stock Splits

The last stock split was on May 7, 2001. It was a forward split with a ratio of 40.

Last Split Date	May 7, 2001
Split Type	Forward
Split Ratio	40